18
Dec
2025
Revenue for sex-rejecting drugs and surgeries in 2023 were estimated to exceed $4.4 billion.
Today's revenue for sex-rejecting drugs and surgeries in 2023 were estimated in one study to exceed $4.4 billion and on track to exceed $7.8 billion by 2030.